Psychedelic stocks have recently been punished by the market. The flip-side is that many well-capitalized companies now offer spectacular value propositions.
Ketamine Wellness Centers (KWC) Announces Plans to Expand Operations into Salt Lake City and Reno
Delic Holding Corp's subsidiary, Ketamine Wellness Centers, is planning to open two new clinics, in Salt Lake City, Utah
Novamind Partners with Uruguay-Based Bienstar Wellness to Develop Latin America's First Integrative Mental Health Clinic Network
Novamind expands its treatment footprint via a new partnership with Uruguay-based Bienstar Wellness.
COMPASS Pathways announces further positive results from groundbreaking phase IIb trial of investigational COMP360 psilocybin therapy for treatment-resistant depression
Compass Pathways provides further details on its Phase IIb results for the treatment of Treatment Resistant Depression, including reporting of additional "patient improvements".
Albert Labs (CSE: ABRT) Receive Conditional Approval for CSE Listing & Appoint Chrystal Capital Partners to Advise on European Listing
UK-based Albert Labs receives conditional approval from the Canadian Securities Exchange (CSE) to commence trading under the symbol "ABRT". Trading expected to commence in early 2022.
Cybin Announces FDA Investigational New Drug and Institutional Review Board Approvals for a Co-Funded Phase 2 Clinical Trial to Treat Frontline Clinicians Experiencing COVID-Related Distress
Cybin seeks FDA approval for a new Phase 2 clinical trial aimed at treating "distress" among frontline healthcare practitioners.
Novamind Reports Fiscal Q1 Financial Results and Operating Highlights
Multistate expansion underway, signed LOI to acquire Arizona-based mental health practice.
atai Life Sciences Increases its Ownership Position in COMPASS Pathways
atai Life Sciences adds to its holding in Compass Pathways, raising its ownership interest back to 20.8%.
Red Light Holland Reports Second Quarter 2021 Results
Red Light Holland reports its results for Q2 fiscal 2021. - Quarterly revenues up to CAD$485,738 - A 64% increase in gross profit - 56% increase in the number of retail outlets selling TRIP products
Cybin Awards Grant for Psychedelic Treatment Clinic to Benefit Underserved Communities
The program aims to become one of the first hospital-based clinical sites to offer psychedelic medicine in the United States.
Novamind Unveils New Logo and Invests in Unified Brand
Novamind announces unified branding of all subsidiaries and brands, and includes a new corporate logo.
Seelos Therapeutics Raises $20 Million in Private Placement of Senior Secured Convertible Note
Seelos Therapeutics announces $20 million in new funding via convertible note, with an option for an additional $30 million.
